Synedica Melanotan II 20mg Nasal Spray
Synedica Melanotan II 20mg Nasal Spray is a research-focused peptide product containing a total of 20mg of Melanotan II (MT-II). It is designed for laboratory, analytical and scientific research involving melanocortin peptides and related receptor pathways.
Melanotan II is a synthetic cyclic peptide analogue related to alpha-melanocyte-stimulating hormone (α-MSH). Scientific research has investigated MT-II because of its activity across melanocortin receptor pathways. Researchers can explore the molecular properties, receptor interactions and biological activity of this peptide within appropriate controlled research environments.
Synedica Melanotan II 20mg Nasal Spray Overview
| Specification | Product Information |
|---|---|
| Product | Synedica Melanotan II 20mg Nasal Spray |
| Compound | Melanotan II (MT-II) |
| Total Amount | 20mg |
| Format | Nasal spray |
| Research Area | Melanocortin peptide research |
| Product Category | Research / Cosmetic Research |
| Intended Use | Research and development purposes only |
What Is Melanotan II?
Melanotan II, commonly abbreviated as MT-II, is a synthetic cyclic peptide analogue derived from research surrounding α-MSH and the melanocortin receptor system. Research has examined its interaction with melanocortin receptors and its effects in experimental models.
A published pharmacological study described Melanotan II as a potent, non-selective melanocortin receptor agonist and investigated structural modifications intended to produce compounds with different receptor selectivity profiles. Read the published Journal of Medicinal Chemistry research on Melanotan II and melanocortin receptors.
Melanotan II Nasal Spray Research
The nasal-spray format provides a research formulation for investigating peptide delivery through the nasal route. Intranasal peptide delivery is an established area of pharmaceutical research because researchers investigate how peptide characteristics, formulation and delivery systems influence absorption and biological activity.
Research into Melanotan II has also included alternative delivery technologies. Scientific literature has investigated engineered delivery systems for Melanotan II, illustrating the broader interest in peptide formulation and delivery research.
Melanotan II and Melanocortin Research
Melanocortin receptors form a family of G-protein-coupled receptors involved in multiple biological signalling pathways. MT-II has been used as a research compound for investigating these pathways and the pharmacological behaviour of melanocortin receptor agonists.
Historical experimental research investigated the melanotropic activity of MT-II, while later medicinal chemistry studies have explored the structure, receptor affinity and selectivity of compounds derived from or related to Melanotan II.
Research Applications
Researchers may investigate Melanotan II within areas including:
- Melanocortin receptor research
- α-MSH analogue research
- Peptide-receptor interaction studies
- Peptide formulation research
- Nasal peptide delivery research
- Structure-activity relationship investigations
- Analytical peptide research
- Melanocortin signalling studies
Scientific Background
Published literature demonstrates that Melanotan II has been studied experimentally for many years. Early human research investigated the melanotropic activity of MT-II, while subsequent research has examined its pharmacology and interaction with melanocortin receptors.
More recent medicinal chemistry research has used Melanotan II as a molecular starting point for investigating receptor selectivity and peptide structure. These studies demonstrate why MT-II remains relevant to researchers studying melanocortin biology.
Research Quality and Product Handling
Researchers working with peptide products should maintain appropriate laboratory procedures for identification, documentation, handling and storage. Product identity, batch information and analytical documentation should be reviewed where available before experimental use.
For additional research products and peptide kits, visit the Synedica research products collection.
Important Safety and Research Disclaimer
Melanotan II is an investigational research peptide and should not be represented as an approved medicine or cosmetic treatment. This product description is provided for laboratory and scientific research purposes only and does not provide instructions for human use.
Published literature has reported adverse events and safety concerns associated with unregulated Melanotan I and II products. A 2017 review highlighted uncertainties surrounding the preparation, administration and dosage of unregulated melanotan products and reported cases involving changes in melanocytic lesions.
A 2025 case report specifically described a possible association between Melanotan II nasal spray use and oral mucosal malignant melanoma. A single case report cannot establish causation, but it reinforces the importance of treating unregulated MT-II products as investigational substances rather than established consumer treatments.
Do not use this product as a human medicine, tanning treatment or self-administered cosmetic product. Research institutions should follow their applicable laboratory procedures, risk assessments and regulatory requirements.
Frequently Asked Questions
What is Synedica Melanotan II 20mg Nasal Spray?
Synedica Melanotan II 20mg Nasal Spray is a research-focused product containing a total of 20mg of Melanotan II (MT-II) in a nasal-spray format.
What is Melanotan II?
Melanotan II is a synthetic cyclic peptide analogue associated with research into α-MSH and melanocortin receptor pathways.
What does MT-II stand for?
MT-II is a commonly used abbreviation for Melanotan II.
Is Melanotan II an approved medicine?
Melanotan II should be treated as an investigational research compound rather than an approved medicine. It should not be marketed or presented as an established treatment.
Is the Synedica Melanotan II product intended for human use?
No. The product should be positioned strictly for research and development purposes. This page does not provide human administration or dosing instructions.
Why is Melanotan II studied in research?
Researchers have investigated MT-II because of its activity within melanocortin receptor pathways and its usefulness as a model compound in peptide and receptor research.
What quantity does this product contain?
The Synedica catalogue lists Melanotan II as a 20mg total-dose nasal spray.
Explore Synedica Research Products
Explore the wider range of Synedica peptide and research products through our Synedica research products collection.












Reviews
There are no reviews yet.